Immunologic Principles in Kidney Transplantation

Comprehensive Clinical Nephrology: Fourth Edition

Volumn , Issue , 2010, Pages 1119-1133

  Womer, Karl ^a   Rabb, Hamid ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79959809776     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-05876-6.00096-4     Document Type: Chapter

References (47)

1. Huang Y, Rabb H, Womer KL Ischemia-reperfusion and immediate T cell responses. Cell Immunol 2007, 248:4-11.
2. Swaminathan S, Griffin MD First responders: Understanding monocyte-lineage traffic in the acutely injured kidney. Kidney Int 2008, 74:1509-1511.
3. Suarez-Alvarez B, Lopez-Vazquez A, Baltar JM, et al. Potential role of NKG2D and its ligands in organ transplantation: New target for immunointervention. Am J Transplant 2009, 9:251-257.
4. Morelli AE, Thomson AW Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007, 7:610-621.
5. Chalasani G, Dai Z, Konieczny BT, et al. Recall and propagation of allospecific memory T cells independent of secondary lymphoid organs. Proc Natl Acad Sci U S A 2002, 99:6175-6180.
6. Lakkis FG, Arakelov A, Konieczny BT, et al. Immunologic "ignorance" of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 2000, 6:686-688.
7. Pape KA, Kouskoff V, Nemazee D, et al. Visualization of the genesis and fate of isotype-switched B cells during a primary immune response. J Exp Med 2003, 197:1677-1687.
8. Valujskikh A, Lakkis FG In remembrance of things past: Memory T cells and transplant rejection. Immunol Rev 2003, 196:65-74.
9. Adams AB, Williams MA, Jones TR, et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003, 111:1887-1895.
10. Schwartz RS Shattuck lecture: Diversity of the immune repertoire and immunoregulation. N Engl J Med 2003, 348:1017-1026.
11. Hennecke J, Wiley DC Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA0101 and DRB10401): Insight into TCR cross-restriction and alloreactivity. J Exp Med 2002, 195:571-581.
12. Gokmen MR, Lombardi G, Lechler RI The importance of the indirect pathway of allorecognition in clinical transplantation. Curr Opin Immunol 2008, 20:568-574.
13. Steele DJ, Laufer TM, Smiley ST, et al. Two levels of help for B cell alloantibody production. J Exp Med 1996, 183:699-703.
14. Brennan TV, Jaigirdar A, Hoang V, et al. Preferential priming of alloreactive T cells with indirect reactivity. Am J Transplant 2009, 9:709-718.
15. Bevan MJ Cross-priming. Nat Immunol 2006, 7:363-365.
16. Jones EY MHC class I and class II structures. Curr Opin Immunol 1997, 9:75-79.
17. Bouvier M, Wiley DC Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. Science 1994, 265:398-402.
18. Dessen A, Lawrence CM, Cupo S, et al. X-ray crystal structure of HLA-DR4 (DRA0101, DRB10401) complexed with a peptide from human collagen II. Immunity 1997, 7:473-481.
19. Gao X, Nelson GW, Karacki P, et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 2001, 344:1668-1675.
20. Zou Y, Stastny P, Susal C, et al. Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med 2007, 357:1293-1300.
21. Bates RL, Frampton G, Rose ML, et al. High diversity of non-human leukocyte antigens in transplant-associated coronary artery disease. Transplantation 2003, 75:1347-1350.
22. Reiser JB, Darnault C, Guimezanes A, et al. Crystal structure of a T cell receptor bound to an allogeneic MHC molecule. Nat Immunol 2000, 1:291-297.
23. Wange RL, Samelson LE Complex complexes: Signaling at the TCR. Immunity 1996, 5:197-205.
24. Li XC, Rothstein DM, Sayegh MH Costimulatory pathways in transplantation: Challenges and new developments. Immunol Rev 2009, 229:271-293.
25. Mandelbrot DA, Kishimoto K, Auchincloss H, et al. Rejection of mouse cardiac allografts by costimulation in trans. J Immunol 2001, 167:1174-1178.
26. Li XC, Rothstein DM, Sayegh MH Costimulatory pathways in transplantation: Challenges and new developments. Immunol Rev 2009, 229:271-293.
27. H2. Nat Immunol 2005, 6:1069-1070.
28. Ouyang W, Kolls JK, Zheng Y The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28:454-467.
29. Willinger T, Freeman T, Hasegawa H, et al. Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets. J Immunol 2005, 175:5895-5903.
30. Barry M, Bleackley RC Cytotoxic T lymphocytes: All roads lead to death. Nat Rev Immunol 2002, 2:401-409.
31. Buzza MS, Bird PI Extracellular granzymes: Current perspectives. Biol Chem 2006, 387:827-837.
32. Al-Lamki RS, Wang J, Skepper JN, et al. Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants. Lab Invest 2001, 81:1503-1515.
33. Young NT Immunobiology of natural killer lymphocytes in transplantation. Transplantation 2004, 78:1-6.
34. Einecke G, Mengel M, Hidalgo L, et al. The early course of kidney allograft rejection: Defining the time when rejection begins. Am J Transplant 2009, 9:483-493.
35. Einecke G, Fairhead T, Hidalgo LG, et al. Tubulitis and epithelial cell alterations in mouse kidney transplant rejection are independent of CD103, perforin or granzymes A/B. Am J Transplant 2006, 6:2109-2120.
36. Colvin RB Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 2007, 18:1046-1056.
37. + cells in renal allografts during acute rejection. Am J Transplant 2007, 7:914-922.
38. Colvin RB, Smith RN Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005, 5:807-817.
39. Rahimi S, Qian Z, Layton J, et al. Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts. Am J Transplant 2004, 4:326-334.
40. Ota H, Fox-Talbot K, Hu W, et al. Terminal complement components mediate release of von Willebrand factor and adhesion of platelets in arteries of allografts. Transplantation 2005, 79:276-281.
41. Camerer E, Huang W, Coughlin SR Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A 2000, 97:5255-5260.
42. Womer KL, Vella JP, Sayegh MH Chronic allograft dysfunction: Mechanisms and new approaches to therapy. Semin Nephrol 2000, 20:126-147.
43. Sis B, Campbell PM, Mueller T, et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007, 7:1743-1752.
44. Robertson H, Ali S, McDonnell BJ, et al. Chronic renal allograft dysfunction: The role of T cell-mediated tubular epithelial to mesenchymal cell transition. J Am Soc Nephrol 2004, 15:390-397.
45. Salama AD, Womer KL, Sayegh MH Clinical transplantation tolerance: Many rivers to cross. J Immunol 2007, 178:5419-5423.
46. Fudaba Y, Spitzer TR, Shaffer J, et al. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: In vivo and in vitro analyses. Am J Transplant 2006, 6:2121-2133.
47. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008, 358:353-361.